Identification of 2-(4-pyridyl)thienopyridinones as GSK-3beta inhibitors
The structure was published by Gentile, G., Bernasconi, G., Pozzan, A., et al., Cutler, G., Neu, M., and Takada, M., in 2011 in a paper entitled "Identification of 2-(4-Pyridyl)Thienopyridinones as Gsk-3Beta Inhibitors." (abstract).
This crystal structure was determined using X-ray diffraction at a resolution of 2.37 Å and deposited in 2011.
The experimental data on which the structure is based was also deposited.
This PDB entry contains a complex of 2 biomacromolecules, namely GLYCOGEN SYNTHASE KINASE-3 BETA and PROTO-ONCOGENE FRAT1.
It also contains one or more heterogenic compounds (e.g., ligands, co-factors, ions, modified amino acids, etc.); see here for a complete list.
The molecule has more than one probable quaternary state observed. For more details see the quaternary structure page.
The following tables show cross-reference information to other databases (to obtain a list of all PDB entries sharing the same property or classification, click on the magnifying glass icon):
This entry contains 2 unique UniProt proteins: